Curriculum vitae

PROFILE

Accomplished Board-level Director and Non-Executive Director (NED) with extensive experience in the Life Sciences, Biotech, and medical sectors. Proven track record in driving commercial growth, scaling multi-million-pound international operations, and leading transformational change within both established and emerging businesses. Expertise in governance, risk management, M&A, and strategic direction. Adept at building high-performing teams, securing investment, and navigating complex global markets.

CORE COMPETENCIES

• Board Governance & NED leadership

• Corporate strategy 

• P&L accountability (£32M+ T/O)

• Organisational growth 

• Change management

• M&A, Investment 

• Private Equity engagement

• Regulatory & Compliance oversight

• Strategic partnerships 

• Stakeholder management

• International expansion, market entry 

• 30+ Distributors

• Business Development & revenue scaling 

• 100% YoY Growth

BOARD EXPERIENCE

Governance & Risk Management

PE/VC Investment Advisory

Forensic Science 

Medical Diagnostics

International Business Expansion & Market Strategy

• NED for ReadyGo Diagnsotics. offering devices and assays designed to simplify diagnostic testing, making it more accessible and decentralised.

• Executive board member at ANGLE.  Small executive management board and a wider senior management committee. 

Setting strategy, resource management and remuneration.
Attended each monthly board meeting updating the chairman and NED’s on strategy and development.

• Global leadership member at Premaitha, reporting to the CEO. Attended monthly board meetings to help set global strategy.
  
  

• Executive management board at Epistem. Three senior management executive team. Setting strategy and commercial channels. Attendance at board meetings addressing the development of and manufacture of the device and subsequent business development.
  
  

• UK board of directors at Olympus. Setting commercial strategy, resource requirements and managing risk. Monthly board meeting addressing integration of disparate divisions.
  
  

• Board Director at FlightControl ltd. Monthly board meetings addressing finance, asset management and expenditure
  
  

• Executive management board at LGC. Monthly meeting addressing sales growth, international expansion, and HR situations.
  
  

• Executive steering committee member at Becton Dickinson

NED EXPERIENCE

• 2025 ReadyGo Diagnsotics. offering devices and assays designed to simplify diagnostic testing, making it more accessible and decentralised
  
  

• 2020 Business mentoring for a young start-up company in landscaping
  
  

• 2019  Middle East Medical Portal supporting companies selling into the Middle East
  
  

• 2019  Inception Associates, helping scale up seeded start ups
  
  

• 2019 Consulting for a CTC platform supplier linking with Key Opinion Leaders to help set strategy.
  
  

• 2016 Exec advice on a start-up toxicology testing laboratory in Maryland USA. Setting strategy, market view, marketing, and sales.
  
  

• 2013 12 month M&A advice on two engineering companies, exploring best outcomes for both organisations.
  
  

• Since 1997 Offering Sales and negotiation training courses,
  
  

• Since 1999 Offering Strategic marketing training
  
  
  

CAREER HISTORY 

NLC Management Consultancy: MD 2014 Ongoing

Providing board advisory, strategic consultancy, and NED services across diagnostic and medical sectors.

Key Projects:

• NED ReadyGo Doagnostics, (2025 ongoing) Corporate governance, commercial support, and separate consultancy

• Board Director, Flight Control Ltd (2002 ongoing)  – Ongoing oversight of business strategy and governance.

• NED, Middle East Medical Portal (2019 – 2021) – Guided international market entry strategies.

• NED, Inception Associates (2019 – 2021) – Assisted in scaling biotech and healthcare startups.

• M&A Advisory (2013) – Led due diligence for a non-diagnostic engineering company.

• Startup Advisory (2016) – Advised on the launch of a toxicology testing laboratory in the US.

• Strategic Growth Initiatives (Ongoing) – Sales, negotiation, and marketing training for executive teams.

ANGLE plc  Senior Vice President Commercial Operations  2019 to September 2024

AIM-listed biotechnology company specialising in rare cancer diagnostics.

• Built and led a global commercial team of 22, covering Sales, Marketing, Product Management, and Technical Service.

• Achieved 100% year-on-year growth and established a 30-country distribution network.

• Developed corporate relationships, global commercial channels, and strategic marketing frameworks.

• Oversaw product strategy and liaised with manufacturing for go-to-market success.

Yourgene Health (previously called Premaitha): Chief Commercial Officer 2015 to June 2019

AIM-listed global molecular diagnostics company, focused on non-invasive prenatal testing (NIPT).

• Grew global revenue to $12M within 3 years from launch.

• Led international business development, sales, marketing, client services, and technical support.

• Expanded operations into Europe, the Middle East, and Asia, securing 80 service clients and 35 installations.

• Delivered $8M revenue from the Middle East region alone within two years.

Epistem LTD: Business Director, IVD-Diagnostics 2010 to 2014

Biotechnology company specialising in molecular diagnostics.

• Spearheaded commercialisation of a handheld PCR device for point-of-care testing.

• Developed key strategic partnerships with global diagnostic firms.

• Secured a £2M UK government grant for veterinary and aquaculture diagnostics.

Olympus UK LTD: Director Scientific Diagnostics Division 2007 to 2009

Leading scientific and consumer technology company.

• UK Board Director, overseeing five GMs and a 100-person team.

• Delivered £32M turnover, achieving 12% sales growth in microscopy.

• Led divestiture of the scientific division to Beckman without staff or revenue losses.

LGC: Business Director Forensics 2000 to 2007

Global scientific company providing forensic testing solutions.

• Managed five labs with 250 staff, covering DNA and chemical forensics

• Increased revenue 40% in three years through client-focused initiatives.

• Reduced operational costs 25% over two years through process optimisation.

• Led successful acquisition and integration of a competitor.

MSI, (Marketing, Sales and Implementation) Managing Consultant  1999 to 2000

Roche, Head of Marketing, Laboratory Division                                      1998 to 1999

Becton Dickinson, Diagnostic Business Director, Microbiology              1987 to 1998

Miles Laboratories, Senior Sales Representative Histology                     1987 to 1987

Laboratory Impex, Clinical Representative Diagnostics                   1984 to 1987

Charing Cross Hospital, Medical Laboratory Scientfic Officer            1977 to 1984

EDUCATION, DEVELOPMENT, QUALIFICATIONS

2004 Business Leadership, 

Henley Business College.

1996 Executive Business Administration and Management,
Harvard University USA.

1982 HNC (Merit) Clinical Biochemistry, 

Westminister University.